AKY MEDICAL LIMITED
- · Thesis: well-run, low negotiation leverage
Opportunity 74/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 105 (micro)Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 105 (micro)| Metric | 2025-07-31 | 2024-07-31 |
|---|---|---|
| Total assets | £4.5k | £1.9k |
| Current assets | £19.8k | £29.4k |
| Net assets | £4.5k | £1.9k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
- • 1 accounts
- • 1 confirmation-statement
Corporate timeline (18 events)Click to expand
- 2026-03-17📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-04-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-04-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-04-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-03-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-04-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-04-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-04-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-04-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-04-27📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2017-02-08📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2016-06-23📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2016-06-23📄change-person-director-company-with-change-dateofficers · CH01
- 2016-06-23📄change-person-director-company-with-change-dateofficers · CH01
- 2016-02-19📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2013-01-25🏢Company incorporatedAs AKY MEDICAL LIMITED
- 2013-01-25➕ABDI, Syed Zeeshan Husain appointeddirector
- 2013-01-25➕ZEESHAN, Erum appointeddirector
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +No director turnover: Company is 13 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
- secondary12+ year tenure: Director in role 13 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Syed Zeeshan Husain Abdi Individual · British · DOB 09/1976 · age 50 | 25–50% | — | 25-50% shares | 01/12/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · AL postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A&S KASKOS LTD→ 09431075 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| ADAHSA LIMITED→ 08922021 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| ADRIT LIMITED→ 11505585 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ADVANCED ORAL IMPLANTS LIMITED→ 07310303 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| AEP LAB LTD→ 07147383 · est 2010 · no financials extracted | — | — | — | — | 16y | — | — |
| AFFECTIONATE LIVING CARE LTD→ 15771678 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ALBAN OSTEOPATHY LTD→ 15782350 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ALEXANDRA SAMPSON LIMITED→ 16816469 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ALIGN WITH MADI LTD→ 15876074 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ALLIED CARE SOLUTIONS LTD→ 14133400 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ALREFAI ALTERNATIVE MEDICAL SERVICES LTD→ 13674716 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AMANDA TOZER LIMITED→ 07196061 · est 2010 · no financials extracted | — | — | — | — | 16y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.